Literature DB >> 24643182

Epidermodysplasia verruciformis.

B Burger1, P H Itin.   

Abstract

Epidermodysplasia verruciformis (EV) is a rare genodermatosis that predisposes certain individuals to developing cutaneous malignancies caused by infectious agents. Mutations in the transmembrane channel gene TMC6 or TMC8 create patient susceptibility to infections by human papillomavirus (HPV) and the development of EV-typical plane warts. Mainly in the UV-exposed regions, affected individuals have a lifelong increased risk for the development of cutaneous malignancy, especially squamous cell carcinoma (SCC). EV is the first disease to correlate cancer and viral infection, therefore EV now serves as the cornerstone to our understanding of viral oncogenesis. The EV model of cutaneous SCC may be applied to the general population; it is suggested that the TMC mutations impair the immunity of the patients, supporting the amplification of specific HPV types. Despite several advances in our comprehension of EV, the pathogenesis of the disease is not well understood.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643182     DOI: 10.1159/000356068

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  8 in total

1.  Cutaneous squamous cell carcinoma associated with Zalophus californianus papillomavirus 1 in a California sea lion.

Authors:  Jennifer A Luff; Rachel E Burns; Michelle Mader; Kara D Priest; Allison D Tuttle
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

Review 2.  Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Qian Zhang; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

Review 3.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

Review 4.  Approach to a Child with Primary Immunodeficiency Made Simple.

Authors:  Dhrubajyoti Sharma; Ankur K Jindal; Amit Rawat; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

5.  Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.

Authors:  Sarah J de Jong; Elias Imahorn; Peter Itin; Jouni Uitto; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova; Bettina Burger
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

6.  The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

Authors:  Sarah Jill de Jong; Amandine Créquer; Irina Matos; David Hum; Vignesh Gunasekharan; Lazaro Lorenzo; Fabienne Jabot-Hanin; Elias Imahorn; Andres A Arias; Hassan Vahidnezhad; Leila Youssefian; Janet G Markle; Etienne Patin; Aurelia D'Amico; Claire Q F Wang; Florian Full; Armin Ensser; Tina M Leisner; Leslie V Parise; Matthieu Bouaziz; Nataly Portilla Maya; Xavier Rueda Cadena; Bayaki Saka; Amir Hossein Saeidian; Nessa Aghazadeh; Sirous Zeinali; Peter Itin; James G Krueger; Lou Laimins; Laurent Abel; Elaine Fuchs; Jouni Uitto; Jose Luis Franco; Bettina Burger; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2018-08-01       Impact factor: 17.579

Review 7.  The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma.

Authors:  Mircea Tampa; Cristina Iulia Mitran; Madalina Irina Mitran; Ilinca Nicolae; Adrian Dumitru; Clara Matei; Loredana Manolescu; Gabriela Loredana Popa; Constantin Caruntu; Simona Roxana Georgescu
Journal:  J Immunol Res       Date:  2020-04-06       Impact factor: 4.818

Review 8.  Viruses and Skin Cancer.

Authors:  Sara Becerril; Roberto Corchado-Cobos; Natalia García-Sancha; Leonor Revelles; David Revilla; Tatiana Ugalde; Concepción Román-Curto; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.